Uspenskaja Olga Aleksandrovna,Успенская Ольга Александровна,Kazarina Larisa Nikolaevna,Казарина Лариса Николаевна,SHevchenko Elena Aleksandrovna,Шевченко Елена Александровна
申请号:
RU2015122345/15
公开号:
RU0002602684C1
申请日:
2015.06.10
申请国别(地区):
RU
年份:
2016
代理人:
摘要:
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to dentistry, and can be used for treating chronic recurrent oral ulceration. Method of treating chronic recurrent oral ulceration includes clinical and biochemical examination of the patient and prescribing the drug therapy, meaning reception of sublingual tablets of sodium aminodihydro-phthalazinedione (Galavit) as per 10 days by 4 tablets and 10 days every second day in a daily dose. Additionally, presence of urogenital infection is detected using real-time polymerase chain reaction and immunological parameters of the oral fluid are examined and if the patients urogenital infection is identified and values of local immunity factors balance coefficient exceed 4.59±0.343 and secretory immunoglobulin A concentration lower than 0.089±0.012 prescribed are the sublingual pills based on sodium aminodihydro-phthalazinedione (Galavit) for 30 days according to the schedule: 10 days - daily - 4 tablets a day, further - 10 days taking pills every second day in the same daily dose, hydroxyzine hydrochloride (Atarax) in 3 receptions by 12.5 mg in the morning and the afternoon, 25 mg in the evening for 4 weeks and intraoral applications with lanthanum triethylene trinitrate in polyhydroxy compounds (Eplan) with the duration of 20-30 minutes 3-4 times a day till complete epithelization of the injury elements.EFFECT: using the invention enables reducing the treatment terms, reducing the epithelization terms, reducing the pain syndrome and the rate of recurrences.1 cl, 2 tbl, 2 exИзобретение относится к медицине, а именно к стоматологии, и может быть использовано для лечения хронического рецидивирующего афтозного стоматита. Способ лечения хронического рецидивирующего афтозного стоматита включает клиническое и биохимическое обследование пациента и назначение медикаментозной терапии, заключающейся в приеме сублингвальных таблеток аминодигидрофталазиндион натрия (галавит) по схеме 10 дней по 4 таблетки и 10 дней через де